Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

SkyPeople Fruit Juice FY12 Profit Rises

SkyPeople Fruit Juice, Inc. (SPU: Quote) reported net income for the fiscal year 2012 of $18.2 million or $0.68 per share, compared to $13.2 million or $0.50 per share for the fiscal year 2011.

Total revenue for the fiscal year 2012 rose 22% to $102.4 million from $84.0 million the prior year, mainly due to an increase in sales of concentrated pear juice, fruit juice beverages and fresh fruit and vegetables which was partially offset by a decrease in the sales of concentrated kiwifruit juice and kiwifruit puree and concentrated apple juice and apple aroma.

Click here to receive FREE breaking news email alerts for SkyPeople Fruit Juice Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
LinkedIn Corp., the world's largest online professional network, said Thursday after the markets closed that it swung to a second quarter loss, hurt by higher costs and expenses even as revenue surged 47%. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. Kraton Performance Polymers, Inc. (KRA), Wednesday reported second-quarter net income of $11.1 million or $0.33 per share, up from $3.8 million or $0.12 per share last year. Adjusted earnings improved to $0.46 per share from $0.15 per share last year. Revenues for the quarter dropped to $323.8... Organic grocer Whole Foods Market, Inc. said Wednesday after the markets closed that its third quarter profit rose 6.3% from last year, as same-store sales increased 3.9%. The company's quarterly earnings per share also came in above analysts' expectations, but its quarterly sales fell shy of analyst' forecast.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.